Sonja Broer, PhD, Florian Heyd, PhD, Rosella Di Sapia, PhD
The ASO developed by this team activates a “cold shock” protein named RBM3 that protects brain cells—without needing to cool the body.
Mahboubeh Ahmadi, PhD
This project will study how epilepsy changes the way CCK interneurons work and whether fixing their activity can reduce seizures and improve memory, motivation, and behavior.
Aswathy AmmothumKandy, PhD
In this project, she and her team will study why these cells stay in a disease state in epilepsy and look for ways to help them return to normal.
Alex Felix, PhD
The goal of this project is to develop a novel Antisense Oligonucleotide (ASO) strategy to treat DEE syndromes by changing how certain genes are processed within the cell.
Christos Lisgaras, PhD
Dr. Lisgaras and his team will test whether precise control of HFOs can provide powerful new therapeutic options. If successful, this work could pave the way for innovative treatments that improve seizure control and transform epilepsy care.
Henrik Klitgaard, PhD & Janine Erler, PhD